Beer elicits vasculoprotective effects through Akt/eNOS activation

European Journal of Clinical Investigation

Volumn 44, Issue 12, 2014, Pages 1177-1188

  Vilahur, Gemma ^a   Casani, Laura ^a   Mendieta, Guiomar ^a   Lamuela Raventos, Rosa M ^b,c   Estruch, Ramon ^b,c   Badimon, Lina ^a,d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Animal model; Antioxidant; Beer; Coronary; Vascular endothelial function

Indexed keywords

ACETYLCHOLINE; ALANINE; ALAPROCLATE; ALCOHOL; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; N(G) METHYLARGININE; ONCOPROTEIN; TRIACYLGLYCEROL; VASODILATOR AGENT;

ANALOGS AND DERIVATIVES; ANIMAL; BEER; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG EFFECTS; DYSLIPIDEMIA; FEMALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; RANDOMIZATION; VASCULAR ENDOTHELIUM; VASODILATATION; WESTERN DIET;

ACETYLCHOLINE; ALANINE; ANIMALS; BEER; CHOLESTEROL; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIET, WESTERN; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ETHANOL; FEMALE; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; ONCOGENE PROTEIN V-AKT; OXIDATIVE STRESS; RANDOM ALLOCATION; SUS SCROFA; SWINE; TRIGLYCERIDES; VASODILATION; VASODILATOR AGENTS;

EID: 84912125270     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12352     Document Type: Article

References (47)

1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671.
2. Pai JK, Mukamal KJ, Rimm EB. Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J 2012;33:1598-605.
3. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994;272:929-33.
4. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993;341:1103-4.
5. Vilahur G, Casani L, Guerra JM, Badimon L. Intake of fermented beverages protect against acute myocardial injury: target organ cardiac effects and vasculoprotective effects. Basic Res Cardiol 2012;107:291.
6. Sato M, Maulik N, Das DK. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann N Y Acad Sci 2002;957:122-35.
7. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ 1996;312:731-6.
8. Estruch R, Sacanella E, Mota F, Chiva-Blanch G, Antunez E, Casals E et al. Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: a randomised cross-over trial. Nutr Metab Cardiovasc Dis 2011;21:46-53.
9. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999;319:1523-8.
10. Mano T, Masuyama T, Yamamoto K, Naito J, Kondo H, Nagano R et al. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J 1996;131:231-8.
11. Luscher TF, Tanner FC, Tschudi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993;44:395-418.
12. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
13. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
14. Schachinger V, Zeiher AM. Atherosclerosis-associated endothelial dysfunction. Z Kardiol 2000;89 (Suppl 9):IX/70-4.
15. Cuevas AM, Guasch V, Castillo O, Irribarra V, Mizon C, San Martin A et al. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers. Lipids 2000;35:143-8.
16. Teragawa H, Fukuda Y, Matsuda K, Higashi Y, Yamagata T, Matsuura H et al. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 2002;165:145-52.
17. Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N. Does a glass of red wine improve endothelial function? Eur Heart J 2000;21:74-8.
18. Guarda E, Godoy I, Foncea R, Perez DD, Romero C, Venegas R et al. Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol 2005;104:35-8.
19. Napoli R, Cozzolino D, Guardasole V, Angelini V, Zarra E, Matarazzo M et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism 2005;54:306-13.
20. Kiviniemi TO, Saraste A, Toikka JO, Saraste M, Raitakari OT, Parkka JP et al. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve. Atherosclerosis 2007;195:e176-81.
21. Chiva-Blanch G, Urpi-Sarda M, Ros E, Arranz S, Valderas-Martinez P, Casas R et al. Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ Res 2012;111:1065-8.
22. Vilahur G, Casani L, Juan-Babot O, Guerra JM, Badimon L. Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction. Atherosclerosis 2012;224:368-76.
23. Vilahur G, Casani L, Pena E, Duran X, Juan-Babot O, Badimon L. Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction. Atherosclerosis 2009;206:95-101.
24. Saitoh S, Saito T, Ohwada T, Ohtake A, Onogi F, Aikawa K et al. Morphological and functional changes in coronary vessel evoked by repeated endothelial injury in pigs. Cardiovasc Res 1998;38:772-81.
25. Dorn JM, Hovey K, Williams BA, Freudenheim JL, Russell M, Nochajski TH et al. Alcohol drinking pattern and non-fatal myocardial infarction in women. Addiction 2007;102:730-9.
26. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:147-63.
27. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998;82:1298-305.
28. Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int 2009;76:437-44.
29. Anttila P, Jarvi K, Latvala J, Romppanen J, Punnonen K, Niemela O. Biomarkers of alcohol consumption in patients classified according to the degree of liver disease severity. Scand J Clin Lab Invest 2005;65:141-51.
30. Caballeria J. Current concepts in alcohol metabolism. Ann Hepatol 2003;2:60-8.
31. Crystal GJ, Gurevicius J, Salem MR, Zhou X. Role of adenosine triphosphate-sensitive potassium channels in coronary vasodilation by halothane, isoflurane, and enflurane. Anesthesiology 1997;86:448-58.
32. Zhou X, Abboud W, Manabat NC, Salem MR, Crystal GJ. Isoflurane-induced dilation of porcine coronary arterioles is mediated by ATP-sensitive potassium channels. Anesthesiology 1998;89:182-9.
33. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010;2010:453892.
34. Martinez Alvarez JR, Belles VV, Lopez-Jaen AB, Marin AV, Codoner-Franch P. Effects of alcohol-free beer on lipid profile and parameters of oxidative stress and inflammation in elderly women. Nutrition 2009;25:182-7.
35. Brenn T. The Tromso heart study: alcoholic beverages and coronary risk factors. J Epidemiol Community Health 1986;40:249-56.
36. De Keukeleire D, De Cooman L, Rong H, Heyerick A, Kalita J, Milligan SR. Functional properties of hop polyphenols. Basic Life Sci. 1999;66:739-60.
37. Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol 1999;37:271-85.
38. Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML et al. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem 2000;48:3876-84.
39. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002;106:1614-7.
40. Venkov CD, Myers PR, Tanner MA, Su M, Vaughan DE. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression. Thromb Haemost 1999;81:638-42.
41. Xue L, Xu F, Meng L, Wei S, Wang J, Hao P et al. Acetylation-dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol-induced eNOS activation. FEBS Lett 2012;586:137-42.
42. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002;106:1652-8.
43. Matsuo S, Nakamura Y, Takahashi M, Ouchi Y, Hosoda K, Nozawa M et al. Effect of red wine and ethanol on production of nitric oxide in healthy subjects. Am J Cardiol 2001;87:1029-31: A6.
44. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, Lin FY et al. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 2010;30:869-77.
45. Vazquez-Agell M, Sacanella E, Tobias E, Monagas M, Antunez E, Zamora-Ros R et al. Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 2007;137:2279-84.
46. Chiva-Blanch G, Urpi-Sarda M, Llorach R, Rotches-Ribalta M, Guillen M, Casas R et al. Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am J Clin Nutr 2012;95:326-34.
47. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8.